EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitScoping Review

General Population Screening For Celiac Disease: A Scoping Review of Evidence, Outcomes, and Implementation

Caroline R Meijer-Boekel, Marisa G Stahl, Imad Absah, Carlo Catassi, Laura Kivelä, Kalle Kurppa, Maureen M Leonard, Elena Lionetti, M Luisa Mearin, Virginia Rodríguez, Maria Naredi Scherman, Edwin Liu und 1 weitere

Clinical Gastroenterology and Hepatology · 2026-10

DOI: 10.1016/j.cgh.2026.09.050 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-10. Verfasst von Caroline R Meijer-Boekel und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Gastroenterology, Leiden University Medical Center, Willem Alexander Children's Hospital, Leiden, The Netherlands.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIMS: Early diagnosis of celiac disease (CeD) through general population screening remains controversial. This review summarizes the remaining evidence gaps limiting implementation of population-based screening for CeD. METHODS: A scoping review was conducted in accordance with the PRISMA-ScR. PubMed was searched for literature related to CeD-screening published up to April 18, 2025. Twelve paired reviewers independently screened selected abstracts and assessed full texts. Included articles were then categorized by primary outcome and summarized descriptively. RESULTS: Of 2,014 abstracts, 172 full-text articles were included with 12 identified outside of the search. Population-based studies indicate that CeD is common yet markedly underdiagnosed, with screening identifying 60-75% of cases not detected by routine clinical practice. Most affected individuals lack clinical features or known affected family members, highlighting the limitation of symptom-driven and targeted screening strategies. Screening-identified individuals benefit from earlier diagnosis with improved health outcomes and quality of life, at the risk of decreased dietary adherence and reduced social functioning. Case-finding, targeted screening, and population-based screening each offer different trade-offs with respect to acceptability, cost, and detection rates. Health economic analyses demonstrate that both case-finding and general population screening can be cost effective, although the magnitude is impacted by diagnostic delay and associated modeled complications. CONCLUSIONS: Current evidence supports potential value of general population screening for CeD. Concerns for health system capacity, cost and management of individuals identified through screening continue to limit consideration of population-based screening for CeD. Implementation studies evaluating real-world outcomes from screening, are essential to address these evidence gaps.

Schlagwörter

Stichwörter der Autor:innen

Celiac DiseaseGluten-FreeScreeningtTG IgA

Autor:innen und Institutionen

  • Department of Paediatric Gastroenterology, Leiden University Medical Center, Willem Alexander Children's Hospital, Leiden, The Netherlands.
  • Department of Pediatrics, Colorado Center for Celiac Disease, Digestive Health Institute, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Mayo Clinic, Rochester, Minnesota.
  • Department of Pediatrics, Polytechnic University of Marche, Ancona, Italy.
  • Faculty of Medicine and Health Technology, Celiac Disease Research Center, Tampere University, Tampere, Finland; Children's Hospital, and Paediatric Research Centre, University of Helsinki, Helsinki University Hospital,…
  • Faculty of Medicine and Health Technology, Celiac Disease Research Center, Tampere University, Tampere, Finland; Tampere Centre for Child, Adolescent and Maternal Health Research, Tampere University and Tampere Universi…

Zitieren

APA

Meijer-Boekel, C. R., Stahl, M. G., Absah, I., Catassi, C., Kivelä, L., Kurppa, K., Leonard, M. M., Lionetti, E., Mearin, M. L., Rodríguez, V., Scherman, M. N., Liu, E., & Agardh, D. (2026). General Population Screening For Celiac Disease: A Scoping Review of Evidence, Outcomes, and Implementation. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2026.09.050

Vancouver

Meijer-Boekel CR, Stahl MG, Absah I, Catassi C, Kivelä L, Kurppa K, et al. General Population Screening For Celiac Disease: A Scoping Review of Evidence, Outcomes, and Implementation. Clinical Gastroenterology and Hepatology. 2026. doi:10.1016/j.cgh.2026.09.050

BibTeX
@article{MeijerBoekel2026,
  author = {Meijer-Boekel, Caroline R and Stahl, Marisa G and Absah, Imad and Catassi, Carlo and Kivelä, Laura and Kurppa, Kalle and Leonard, Maureen M and Lionetti, Elena and Mearin, M Luisa and Rodríguez, Virginia and Scherman, Maria Naredi and Liu, Edwin and Agardh, Daniel},
  title = {General Population Screening For Celiac Disease: A Scoping Review of Evidence, Outcomes, and Implementation},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2026},
  doi = {10.1016/j.cgh.2026.09.050}
}
Kostenlos starten →